about
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade dis...
Read More
7.90
0.00
(0.00%)
925.6K
XNAS Volume
XNAS 03 Sep, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Arvinas Inc is on 05 Sep 2025 for the purpose of Cantor Global Healthcare Conference
See details
Low Financial Strength
Expensive Valuation
Technically Neutral
Momentum Trap
These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks.
View Similar
Embed DVM
Arvinas Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..